173 results on '"Tober-Lau, Pinkus"'
Search Results
2. Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics
3. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study*
4. The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
5. Monkeypox in-patients with severe anal pain
6. Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
7. Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy
8. Cystatin C is associated with adverse COVID-19 outcomes in diverse populations
9. Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents
10. A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study
11. A survey among physicians in surgery and anesthesiology departments after the first surge of SARS-CoV-2 infections in Germany: Preparing for further challenges ahead
12. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
13. Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: a prospective study on subtle and persistent cardiovascular involvement
14. Cross-platform Clinical Proteomics using the Charite Open Standard for Plasma Proteomics (OSPP)
15. Role of the complement system in Long COVID
16. Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
17. A time-resolved proteomic and prognostic map of COVID-19
18. Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany
19. Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021
20. Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
21. Impfungen als Schlüssel der Pandemiebewältigung
22. Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics
23. Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
24. Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy
25. Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics
26. Brain magnetic resonance imaging in imported malaria
27. Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers
28. Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
29. Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis
30. Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
31. Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
32. The human host response to monkeypox infection: a proteomic case series study
33. Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
34. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
35. Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
36. Monkeypox in-patients with severe anal pain
37. Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy.
38. OxoScan-MS: Oxonium ion scanning mass spectrometry facilitates plasma glycoproteomics in large scale
39. Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
40. SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
41. Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination
42. Delineating antibody escape from Omicron sublineages
43. Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
44. A proteomic survival predictor for COVID-19 patients in intensive care
45. Complement activation induces excessive T cell cytotoxicity in severe COVID-19
46. Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19
47. Durability of Omicron-neutralizing serum activity following mRNA booster immunization in elderly individuals
48. Complement activation induces excessive T cell cytotoxicity in severe COVID-19
49. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
50. A multiplex protein panel assay determines disease severity and is prognostic about outcome in COVID-19 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.